Increased BCR responsiveness in B cells from patients with chronic GVHD
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased BCR responsiveness in B cells from patients with chronic GVHD
Authors
Keywords
-
Journal
BLOOD
Volume 123, Issue 13, Pages 2108-2115
Publisher
American Society of Hematology
Online
2014-02-15
DOI
10.1182/blood-2013-10-533562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Morphea-like lesions Associated with Chronic Graft-versus-host Disease after Cord Blood Transplantation
- (2014) Y Kawakami et al. ACTA DERMATO-VENEREOLOGICA
- The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway
- (2013) Edina Schweighoffer et al. IMMUNITY
- Bone Marrow B cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development
- (2012) Yuri Fedoriw et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
- (2012) J. L. Allen et al. BLOOD
- Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level
- (2012) Franklin R. Toapanta et al. Frontiers in Cellular and Infection Microbiology
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia
- (2010) Z. Kuzmina et al. BLOOD
- Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease
- (2010) S. Sarantopoulos et al. BLOOD
- Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
- (2010) S. J. Kim et al. HAEMATOLOGICA
- B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor
- (2010) Fabienne Mackay et al. IMMUNOLOGICAL REVIEWS
- CD20, AIF-1 and TGF-β in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies
- (2010) Julie M Wu et al. MODERN PATHOLOGY
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease
- (2008) Hildegard T. Greinix et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rituximab as salvage therapy for refractory chronic GVHD
- (2008) M Mohty et al. BONE MARROW TRANSPLANTATION
- Recognizing and Managing Chronic Graft-Versus-Host Disease
- (2008) S. J. Lee et al. Hematology-American Society of Hematology Education Program
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now